Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients.
about
Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the HaystackMolecular characterization and heterogeneity of circulating tumor cells in breast cancer.Breast Cancer Metastasis Associations with Clinicopathological Characteristics in Mexican Women Younger than 40 Years of AgeMolecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy.Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistry.Evaluation of Circulating Endometrial Cells as a Biomarker for Endometriosis.Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer.Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients.About HER2 monitoring using liquid biopsies in patients with gastric cancer.Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations.
P2860
Q28067549-71F6864E-F717-455B-9891-FEAE474B05C0Q38621053-DDF3B7AA-4B86-43D5-A2BF-949B5FD8851AQ39054166-52FF148C-A51D-45F5-8441-813CD7F7DA45Q41233528-1FAF6B75-F796-4C5E-B75D-5E76B2E76ED5Q41612814-80D3C352-6795-4669-9B74-17EDE89D17ECQ42267344-4F529CC0-C55A-4EBB-AE31-CF17BC7A7467Q42669105-D7A80043-494C-471A-A976-7AB78B4F0C9DQ47397566-0B2231F5-6466-453A-8ED9-A7D9A5D57D45Q50642054-E70CE0D0-FF7E-45D6-B56A-CCF56597A9C8Q51081148-A9415204-C1CD-4924-8897-E062FCE1515EQ55692870-B55EA07E-30C3-4D43-8CD7-AF57F7E59A28
P2860
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Comparison of the HER2, estrog ...... static breast cancer patients.
@ast
Comparison of the HER2, estrog ...... static breast cancer patients.
@en
type
label
Comparison of the HER2, estrog ...... static breast cancer patients.
@ast
Comparison of the HER2, estrog ...... static breast cancer patients.
@en
prefLabel
Comparison of the HER2, estrog ...... static breast cancer patients.
@ast
Comparison of the HER2, estrog ...... static breast cancer patients.
@en
P2093
P2860
P50
P1433
P1476
Comparison of the HER2, estrog ...... static breast cancer patients.
@en
P2093
DETECT Study Group
Klaus Pantel
Mitra Tewes
Volkmar Müller
Wolfgang Janni
P2860
P2888
P356
10.1186/S12885-016-2587-4
P407
P577
2016-07-25T00:00:00Z
P6179
1017036865